CD22 is required for formation of memory B cell precursors within germinal centers

CD22 is a BCR co-receptor that regulates B cell signaling, proliferation and survival and is required for T cell-independent Ab responses. To investigate the role of CD22 during T cell-dependent (TD) Ab responses and memory B cell formation, we analyzed Ag-specific B cell responses generated by wild...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 12; no. 3; p. e0174661
Main Authors Chappell, Craig P, Draves, Kevin E, Clark, Edward A
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 27.03.2017
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:CD22 is a BCR co-receptor that regulates B cell signaling, proliferation and survival and is required for T cell-independent Ab responses. To investigate the role of CD22 during T cell-dependent (TD) Ab responses and memory B cell formation, we analyzed Ag-specific B cell responses generated by wild-type (WT) or CD22-/- B cells following immunization with a TD Ag. CD22-/- B cells mounted normal early Ab responses yet failed to generate either memory B cells or long-lived plasma cells, whereas WT B cells formed both populations. Surprisingly, B cell expansion and germinal center (GC) differentiation were comparable between WT and CD22-/- B cells. CD22-/- B cells, however, were significantly less capable of generating a population of CXCR4hiCD38hi GC B cells, which we propose represent memory B cell precursors within GCs. These results demonstrate a novel role for CD22 during TD humoral responses evident during primary GC formation and underscore that CD22 functions not only during B cell maturation but also during responses to both TD and T cell-independent antigens.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Conceptualization: CPC EAC.Data curation: CPC KED.Formal analysis: CPC KED.Funding acquisition: EAC.Investigation: CPC KED.Methodology: CPC KED EAC.Project administration: EAC.Resources: CPC EAC.Supervision: EAC.Validation: CPC KED.Visualization: CPC KED.Writing – original draft: CPC.Writing – review & editing: CPC EAC.
Competing Interests: The authors have declared that no competing interests exist.
Current address: Immunology Discovery at Merck Research Laboratories, Boston, Massachusetts
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0174661